ZymoGenetics: Clinical Trials

3 trials sponsored by ZymoGenetics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1
Phase 21Terminated 1

Follow ZymoGenetics: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
Atacicept, Mycophenolate mofetil, Placebo - Lupus Nephritis
Phase 2 / Phase 3TerminatedEMD Serono62007-12-012016-03-23
Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
rThrombin - Spinal Surgery, Vascular Surgery
Phase 3CompletedZymoGenetics2342007-06-012012-01-13
Study of Recombinant Human Thrombin for Bleeding During Surgery
rThrombin, bovine thrombin - Surgical Hemostasis
Phase 3CompletedZymoGenetics4012005-10-012009-03-09

Conditions studied

Lupus Nephritis (1)  ·  Nephritis (1)

Interventions

recombinant human thrombin (2)  ·  Adrenal Cortex Hormones (1)  ·  Mycophenolic Acid (1)  ·  TACI receptor-IgG Fc fragment fusion protein (1)  ·  Thrombin (1)

Countries

United States (3)  ·  Czechia (1)  ·  Malaysia (1)  ·  Singapore (1)  ·  Taiwan (1)

Top investigators

Allan Alexander, MD, CPI (1)  ·  Fred Weaver, MD (1)  ·  Kenneth Renkens, MD (1)  ·  Thomas C Reynolds, MD, PhD (1)  ·  William Chapman, MD (1)

Results publications

PMID 17660072, PMID 18440754, PMID 19651065, PMID 20980172, PMID 22325903